The EEG as indicator of the cholinergic deficit in Alzheimer's disease;Das EEG als indikator des cholinergen defizits bei der Alzheimerschen krankheit

Fortschritte der Neurologie Psychiatrie

Volumn 68, Issue 8, 2000, Pages 352-356

  Adler, G ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT;

ALZHEIMER DISEASE; BRAIN PERFUSION; CELL ACTIVITY; CHOLINERGIC ACTIVITY; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG RESPONSE; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAM; HISTOPATHOLOGY; HUMAN; NERVE CELL; NERVE PROJECTION; NEUROPSYCHOLOGY; PARASYMPATHETIC INNERVATION; REVIEW;

ALZHEIMER DISEASE; AUTONOMIC NERVOUS SYSTEM DISEASES; ELECTROENCEPHALOGRAPHY; HUMANS; PARASYMPATHETIC NERVOUS SYSTEM;

EID: 0033841025     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-11803     Document Type: Review

References (72)

1. Brainstem reticular formation and activation of the EEG
2. The ascending cholinergic reticular systems: Neocortical, olfactory and subcortical projektions
3. Uber die Wirkung von Scopolamin und ahnlichen Substanzen auf bedingte Reaktionen
4. Effects of scopolamine and atropine on electroencephalographic and behavioral reactions due to hypothalamic stimulation
5. Acetylcholine facilitation, atropine block of synaptic excitation of cortical neurons
6. Acetylcholinesterase rich projections from the basal forebrain of the rhesus monkey to neocortex
7. Cholinergic nucleus basalis neurons may influence the cortex via the thalamus
8. Distribution of cholinergic neurons in rat brain: Demonstrated by the immunohistochemical localization of choline acetyltransferase
9. The thalamus as a neural oscillator
10. Systemic regional differences in the cholinergic innervation of the primate cerebral cortex: Distribution of enzyme activity and some behavioral implications
11. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6)
12. Afferent connections of the fore brain. Cholinergic projection neurons, with special reference to monoaminergic and peptidergic fibers
13. Cholinergic and noradrenergic modulation of thalamocortical processing
14. Reticularis thalami revisited. Activity changes during shifts in states of vigilance
15. Nucleus basalis and thalamic control of neocortical activity in freely moving rat
16. Excitatory effect of acetylcholine on different types of neurons in the first somatosensory neocortex of the rat: Laminar distribution and pharmacological characteristics
17. Voltage clamp analysis of cholinergic action in the hippocampus
18. Activity of identified cortically projecting and other basal forebrain neurons during large slow waves and cortical activation in anaesthetized rats
19. Electric activity in the neocortex of freely moving young and aged rats
20. Relationships between EEG delta power and the cortical choline acetyltransferase content
21. The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning
22. Interaction between the alpha2-noradrenergic and muscarinergic systems in the regulation of neocortical high voltage spindles
23. The effects of THA on medial septal lesion-induced memory defects
24. Changes in cortical acetylcholine output induced by modulation of the nucleus basalis
25. Basal forebrain stimulation modifies auditory cortex responsiveness by an action at muscarinic receptos
26. Cellular bases of neocortical activation: Modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine
27. Selective loss of central cholinergic neurons in Alzheimer's disease
28. The cholinergic hypothesis of geriatric memory dysfunction
29. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain
30. Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data
31. Alzheimer's disease: Choline acetyltransferase activity in brain tissues from clinical and pathological subgroups
32. The cholinergic hypothesis - Ten years on
33. Central cholinergic system and memory
34. Functional brain studies of cholinergic modulation of memory in humans
35. Aging and spectral analysis of EEG in normal subjects: A link to memory and CSF AChE
36. Decreased ratio of CSF acetylcholinesterase to butylcholinesterase activity in Alzheimer's disease
37. Slowing of electronencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease
38. Effects of scopolamine (0,25-0,75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers
39. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential and verbal memory
40. EEG changes following scopolamine administration in healthy subjects
41. Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls
42. Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG
43. Uber das Elektrenkephalogramm des Menschen. Dritte Mitteilung
44. Uber das Elektrenkephalogramm des Menschen. Funfte Mitteilung
45. Frequency analysis of the resting awake EEG in mild senile dementia of Alzheimer type
46. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type
47. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease
48. Computerized EEG spectral analysis in elderly normal, demented and depressed subjects
49. Topographic EEG changes with normal aging and SDAT
50. The EEG spectra of Alzheimer's disease
51. Quantitative EEG mapping and PET in Alzheimer's disease
52. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment
53. Quantified-EEG in normal aging and dementia
54. Volumetrische Hirnveranderungen und quantitatives EEG bei normalem Altern und Alzheimer-Demenz
55. Correlations of topographical EEG feature with clinical severity in mild and moderate dementia of Alzheimer type
56. Power spectral analysis and cortical coupling of EEG for young and old normal adults
57. Die Bedeutung des EEG bei der Fruh- und Differentialdiagnose der Demenz vom Alzheimer Typ
58. Discrimination between demented patients and normals based on topographic EEG slow wave activity: Comparison between statistics, discriminant analysis and artificial neural network classifiers
59. Quantitative electroencephalography and regional cerebral blood flow: Discriminant analysis between Alzheimer's patients and healthy controls
60. A comparison of ADAS and EEG in the discrimination of patients with dementia of the Alzheimer type from healthy controls
61. A longitudinal EEG study of mild senile dementia of Alzheimer type: Changes at 1 year and at 2,5 years
62. Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: Relation to severity of dementia
63. Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type
64. A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease
65. Serial EEG in Alzheimer's disease: 3 Year follow-up and clinical outcome
66. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease
67. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease
68. Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease
69. Mild cognitive impairment in old-age depression is associated with increased EEG slow-wave power
70. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy
71. Oral tetrahydro-aminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG
72. Short-term effects of rivastigmine treatment in Alzheimer patients